
2026/10/08
CIC bioGUNE contributes to a proposal published in Science to boost innovation in Europe
The article, driven by the INPACT! network, proposes reforms to European funding and academic institutions to make it easier to transfer scientific knowledge to the market.
Europe has world-class scientific research. However, much of that knowledge never turns into new technologies, products or companies with an impact on society. A discovery with potential applications is often left halfway, held back by a lack of funding in the intermediate stages, by complex administrative procedures or by an academic system that does not sufficiently recognise researchers' innovation work. How to bridge this gap between the laboratory and the market is now one of the major questions in European science policy, and it is the subject of a new article published in the journal Science.
CIC bioGUNE, member of BRTA, contributes to this work through researcher Alberto Fernández-Tejada, Ikerbasque Research Professor and head of the centre's Chemical Immunology Laboratory. The article, entitled 'Enhancing Europe's Competitiveness by Empowering Researchers as Innovators', appears in the journal's Policy Forum section.
The paper is an initiative of INPACT!, a network founded in 2023 that brings together more than 120 researchers and innovators in over 20 European countries, most of them funded by the European Research Council (ERC). Fernández-Tejada began his independent career at CIC bioGUNE in 2017 with an ERC Starting Grant and has since secured several ERC Proof of Concept grants, which are designed to explore the practical applications of research results.
The paper analyses the Horizon Europe programme and notes that funding remains fragmented between ERC Proof of Concept grants and the programmes of the European Innovation Council (EIC). Its main recommendation is to integrate Proof of Concept grants into EIC governance to create a more continuous pathway from fundamental research to commercialisation. It also proposes:
- strengthening support for early-stage, high-risk innovation;
- simplifying application processes;
- having national agencies fund excellent projects that pass the European evaluation but miss out on funding owing to budget constraints.
The authors also highlight the role of universities and research centres. To that end, they recommend recognising entrepreneurship in research careers, improving the management of intellectual property and making it easier to pursue patents, industry collaborations and spin-offs.
Reference: Silva Brun A. K. A., Presidente G., et al. Enhancing Europe's Competitiveness by Empowering Researchers as Innovators. Science. DOI: 10.1126/science.ady238.
About CIC bioGUNE
The Centre for Cooperative Research in Biosciences (CIC bioGUNE), member of the Basque Research & Technology Alliance (BRTA), located in the Bizkaia Technology Park, is a biomedical research organisation conducting cutting-edge research at the interface between structural, molecular and cell biology, with a particular focus on generating knowledge on the molecular bases of disease, for use in the development of new diagnostic methods and advanced therapies.
About BRTA
BRTA is an alliance of 4 collaborative research centres (CIC bioGUNE, CIC nanoGUNE, CIC biomaGUNE y CIC energiGUNE) and 13 technology centres (Azterlan, Azti, Ceit, Cidetec, Gaiker, Ideko, Ikerlan, Leartiker, Lortek, Neiker, Tecnalia, Tekniker y Vicomtech) with the main objective of developing advanced technological solutions for the Basque corporate fabric.
With the support of the Basque Government, the SPRI Group and the Provincial Councils of the three territories, the alliance seeks to promote collaboration between the research centres, strengthen the conditions to generate and transfer knowledge to companies, contributing to their competitiveness and outspreading the Basque scientific-technological capacity abroad.
BRTA has a workforce of 3,500 professionals, executes 22 % of the Basque Country's R&D investment, registers an annual turnover of more than 300 million euros and generates 100 European and international patents per year.
See a large version of the first picture

